Activate

The goal of the ACTIVATE study is to look at how differences in the microbiome of a baby may protect, or put a baby at risk, for allergic problems. To do this, the study will measure whether wiping babies born by C-section with their mother’s vaginal fluids (which contains potentially beneficial bacteria; referred to as “vaginal seeding”) right after birth will lower the risk of developing positive allergy tests at one year of age. The RESPOND HEALTH Platform provides the app tool to monitor moms and their baby’s allergies for their first year. Our Platform also alerts study staff when women go into labor providing a way to meet the moms at the hospital and capture on-the-spot data.